Unwavering in our commitment to bring the best science to patients worldwide
Focusing on ground-breaking medicines to address chronic progressive diseases, including rheumatology and dermatology.
Investing in new pathways, technologies and approaches to tackle the most widespread and debilitating cancers.
Discovering compounds that have the potential to treat chronic disabling neurological conditions and impairments, including MS, Parkinson’s Disease and Alzheimer's.
Partnering with patient advocates and leading stakeholders to help address unmet needs across the world for people living with AIDS and hepatitis C.
Seeking solutions for a range of diseases that currently have few or no treatments, including cystic fibrosis, endometriosis, uterine fibroids and diabetic nephropathy.
Leave the AbbVie Hong Kong website
The AbbVie Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in other countries or regions. If you are a resident of a country other than those to which the site is directed, please contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence.The AbbVie Internet site that you have requested may be in a language that differs from your country of origin.
The link below will take you out of the AbbVie family of websites. Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie. The Internet site that you have requested may not be optimized to your screen size. Do you wish to leave this site?